Top Markets
#1 Black Phoenix Black Phoenix +166.58%
#2 Islamic Coin Islamic Coin +158.26%
#3 Glidr Glidr +84.34%
#4 Test Test +23.21%
#5 Cryptopia Cryptopia +21.17%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.42%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +15.72%
#8 DOVU DOVU +11.66%
#9 MarsCoin MarsCoin +11.25%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +11.04%
Coin of the day
Black Phoenix Black Phoenix
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
Rosetta Genomics Ltd. Rosetta Genomics Ltd.

Rosetta Genomics Ltd.

ROSGQ
Xếp hạng trong cổ phiếu #42629
Rosetta Genomics Ltd. is a global entity specializing in genomic diagnostics.... Rosetta Genomics Ltd. is a global entity specializing in genomic diagnostics. The company leverages its proprietary microRNA technologies to offer a range of diagnostic assays, including RosettaGX Cancer Origin, which helps pinpoint the primary source of metastatic cancer; mi-KIDNEY, designed for classifying kidney tumors from pathological specimens; RosettaGX Reveal, used to interpret indeterminate thyroid fine-needle aspirate results; and various mi-LUNG diagnostic tests. In addition to its microRNA-based portfolio, Rosetta Genomics provides UroVysion, a urine-based Fluorescence In Situ Hybridization (FISH) assay. This assay serves as an adjunct to, rather than a substitute for, conventional diagnostic methods, aiding in the initial detection of bladder carcinoma in patients with hematuria and in the ongoing surveillance for tumor recurrence in those previously diagnosed with bladder cancer. The company also offers ERG/PTEN, which are FISH-based tests providing prognostic information for prostate cancer. Furthermore, Rosetta Genomics supplies ALK/ROS1, a set of FISH-based predictive tests specifically intended for individuals with late-stage lung cancer, along with PCR gene mutation analysis for patients with bladder, lung, colon, and melanoma cancers. Its diagnostic solutions are utilized by a diverse group of medical professionals, including oncologists, urologists, endocrinologists, and cytopathologists, empowering them to deliver improved patient care. The company holds a licensing agreement with Max Planck Innovation GmbH, securing rights to its patented microRNA technologies for both diagnostic applications and research initiatives. Moreover, Rosetta Genomics has entered into a collaborative partnership with Meir Medical Center to develop a microRNA classifier, focusing on non-small cell lung cancer patients being considered for immuno-oncology therapies. Established in 2000, Rosetta Genomics Ltd. maintains its headquarters in Rehovot, Israel.
Giá cổ phiếu
$0.0001
Đồng bộ lần cuối: 2026-08-11
Vốn hóa thị trường
$593.00
Thay đổi (1 ngày)
0.00%
Thay đổi (1 năm)
0.00%
Quốc gia
IL
Giao dịch Rosetta Genomics Ltd. (ROSGQ)

Danh mục

Healthcare
Lịch sử chia tách cổ phiếu của Rosetta Genomics Ltd. (ROSGQ)
Cổ phiếu Rosetta Genomics Ltd. (mã: ROSGQ) đã trải qua tổng cộng 0 lần chia tách.
Lần chia tách gần nhất diễn ra vào ngày Aug 13, 2026.
Một cổ phiếu ROSGQ mua trước ngày Aug 13, 2026 hiện tương đương với 0 cổ phiếu ROSGQ.
Danh sách chia tách cổ phiếu
Năm Chia tách Tỷ lệ Tỷ lệ cộng dồn
Không đủ dữ liệu cho ngày được cung cấp.
Chia tách cổ phiếu của các công ty tương tự hoặc đối thủ
Công ty Số lần chia tách cổ phiếu Tỷ lệ cộng dồn Quốc gia
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 8 x34
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 7 x47
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 0 -
CN
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 4 x15
US
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 0 -
US